Morgan Stanley
NBRV

Morgan Stanley’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,351
Closed -$8.08K 7867
2023
Q2
$8.08K Buy
5,351
+1,243
+30% +$1.88K ﹤0.01% 6883
2023
Q1
$7.18K Sell
4,108
-330
-7% -$576 ﹤0.01% 6974
2022
Q4
$8.39K Sell
4,438
-39
-0.9% -$74 ﹤0.01% 6996
2022
Q3
$9K Sell
4,477
-137,031
-97% -$275K ﹤0.01% 7132
2022
Q2
$25K Buy
141,508
+21,661
+18% +$3.83K ﹤0.01% 6909
2022
Q1
$50K Sell
119,847
-334,473
-74% -$140K ﹤0.01% 6709
2021
Q4
$272K Buy
454,320
+355,137
+358% +$213K ﹤0.01% 5895
2021
Q3
$118K Buy
99,183
+7,244
+8% +$8.62K ﹤0.01% 6281
2021
Q2
$125K Buy
91,939
+82,076
+832% +$112K ﹤0.01% 6252
2021
Q1
$16K Sell
9,863
-385,312
-98% -$625K ﹤0.01% 6811
2020
Q4
$956K Buy
395,175
+33,798
+9% +$81.8K ﹤0.01% 4694
2020
Q3
$193K Sell
361,377
-55,567
-13% -$29.7K ﹤0.01% 5140
2020
Q2
$282K Buy
416,944
+81,729
+24% +$55.3K ﹤0.01% 4906
2020
Q1
$193K Sell
335,215
-73,355
-18% -$42.2K ﹤0.01% 4879
2019
Q4
$540K Buy
408,570
+55,248
+16% +$73K ﹤0.01% 4885
2019
Q3
$707K Buy
353,322
+87,904
+33% +$176K ﹤0.01% 4495
2019
Q2
$645K Buy
265,418
+91,869
+53% +$223K ﹤0.01% 4468
2019
Q1
$424K Sell
173,549
-16,495
-9% -$40.3K ﹤0.01% 4646
2018
Q4
$278K Buy
190,044
+1,113
+0.6% +$1.63K ﹤0.01% 5142
2018
Q3
$510K Buy
188,931
+104,497
+124% +$282K ﹤0.01% 4988
2018
Q2
$294K Buy
84,434
+40,973
+94% +$143K ﹤0.01% 5385
2018
Q1
$218K Buy
43,461
+29,697
+216% +$149K ﹤0.01% 5434
2017
Q4
$82K Sell
13,764
-1,251,160
-99% -$7.45M ﹤0.01% 5698
2017
Q3
$10.4M Buy
1,264,924
+1,264,641
+446,870% +$10.4M ﹤0.01% 2233
2017
Q2
$3K Sell
283
-3,301
-92% -$35K ﹤0.01% 6430
2017
Q1
$43K Buy
3,584
+3,301
+1,166% +$39.6K ﹤0.01% 5879
2016
Q4
$2K Sell
283
-200
-41% -$1.41K ﹤0.01% 6399
2016
Q3
$3K Hold
483
﹤0.01% 6336
2016
Q2
$4K Hold
483
﹤0.01% 6272
2016
Q1
$4K Buy
483
+265
+122% +$2.2K ﹤0.01% 6336
2015
Q4
$2K Sell
218
-182
-46% -$1.67K ﹤0.01% 6528
2015
Q3
$4K Buy
+400
New +$4K ﹤0.01% 6426